Drug that skyrocketed 5,000% hasn't come down in price

Posted online October 12, 2015 | 11:36 am

The drug that skyrocketed in price from $13.50 to $750 a pill has yet to come back down.

"We've agreed to lower the price of Daraprim to a price that is more affordable," Martin Shkreli, CEO of Turing Pharmaceuticals, said on ABC World News Tonight on Sept. 24. He did not specify a price or timeline.

Used by cancer and AIDS patients, the drug's price increase sparked a public outcry.

Read more from CNNMoney.

Interim CEO starts at Ozarks Regional YMCA

Comments

No comments on this story |

Please log in to add your comment

Editors' Pick

Open for Business: Crumbl Cookies

Utah-based gourmet cookie chain Crumbl Cookies opened its first Springfield shop; interior design business Branson Upstaging LLC relocated; and Lauren Ashley Dance Center LLC added a second location.

Most Read